The Effect of Radiation Dose and Chemotherapy on Overall Survival in 237 Patients With Stage III Non-Small-Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 5, 2009, Pages 1383-1390

  Wang, Li ^a,d   Correa, Candace R ^a   Zhao, Lujun ^a   Hayman, James ^a   Kalemkerian, Gregory P ^b   Lyons, Susan ^b   Cease, Kemp ^b   Brenner, Dean ^b   Kong, Feng Ming ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Veterans Administration Health Center   (United States)

^d FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Chemotherapy; Dose; NSCLC; Radiation; Stage III

Indexed keywords

BIOLOGICAL ORGANS; CHEMOTHERAPY; COMPUTER OPERATING SYSTEMS; DOSIMETRY; PATIENT MONITORING; REGRESSION ANALYSIS;

CHEMORADIATION; CONCURRENT CHEMORADIATION; DOSE; INDEPENDENT PREDICTORS; MEDIAN SURVIVALS; MEDICALLY INOPERABLE; MULTI VARIABLES; NON-SMALL-CELL LUNG CANCERS; NSCLC; OVERALL SURVIVALS; PERFORMANCE STATUS; RADIATION DOSE; RADIATION THERAPIES; REGRESSION MODELS; SURVIVAL RATES; WEIGHT LOSS;

RADIATION EFFECTS;

CARBOPLATIN; CISPLATIN; ETOPOSIDE; NAVELBINE; PACLITAXEL;

ADULT; AGED; ARTICLE; BIOEQUIVALENCE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIATION; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; RADIOTHERAPY DOSAGE; RELATIVE BIOLOGICAL EFFECTIVENESS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VINBLASTINE;

EID: 62649149839     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.06.1935     Document Type: Article

References (29)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66 2007
2. Furuse K., Fukuoka M., Kawakara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable Stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
3. Curran W.J., Scott C.B., Langer C.J., et al. Long-term benefit is observed in a Phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresectable Stage III NSCLC: RTOG 9410. Proc ASCO 22 (2003) 621A (abstract 2449)
4. Perez C.A., Stanley K., Rubin P., et al. A prospective randomized study of various radiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group. Cancer 45 (1980) 2744-2753
5. Kupelian P.A., Komaki R., and Allen P. Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 36 (1996) 607-613
6. Sibley G.S., Jamieson T.A., Marks L.B., et al. Radiotherapy alone for medically inoperable Stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 40 (1998) 149-154
7. Rengan R., Rosenzweig K.E., Venkatraman E., et al. Improved local control with higher doses of radiation in large-volume Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 741-747
8. Rosenzweig K.E., Fox J.L., Yorke E., et al. Results of a Phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer 103 (2005) 2118-2127
9. Kong F.M., Ten Haken R.K., Schipper M.J., et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 324-333
10. Chen M., Hayman J.A., Ten Haken R.K., et al. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: Is low incidence of regional failure due to incidental nodal Radiation?. Int J Radiat Oncol Biol Phys 64 (2006) 120-126
11. Zhao L., West B.T., Hayman J.A., et al. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 68 (2007) 103-110
12. Belderbos J.S., De Jaeger K., Heemsbergen W.D., et al. First results of a Phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol 66 (2003) 119-126
13. Socinski M.A., Rosenman J.G., Halle J., et al. Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable Stage IIIA/B nonsmall cell lung carcinoma. Cancer 92 (2001) 1213-1223
14. Rosenman J.G., Halle J.S., Socinski M.A., et al. High-dose conformal radiotherapy for treatment of Stage IIIA/IIIB non-small-cell lung cancer: Technical issues and results of a Phase I/II trial. Int J Radiat Oncol Biol Phys 54 (2002) 348-356
15. Socinski M.A., Morris D.E., Halle J.S., et al. Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable Stage IIIA and IIIB non-small-cell lung cancer: A dose-escalation Phase I trial. J Clin Oncol 22 (2004) 4341-4350
16. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 40 (1987) 373-383
17. Perez C.A., Bauer M., Edelstein S., et al. Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys 12 (1986) 539-547
18. Perez C.A., Pajak T.F., Rubin P., et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 59 (1987) 1874-1881
19. Willner J., Baier K., Caragiani E., et al. Dose, volume, and tumor control prediction in primary radiotherapy of nonsmall-cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 382-389
20. Bradley J.D., Ieumwananonthachai N., Purdy J.A., et al. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for nonsmall-cell lung carcinoma. Int J Radiat Oncol Biol Phys 52 (2002) 49-57
21. Schwegler N., Gordic J., Ragaz A., et al. Inoperable non-small cell bronchial carcinoma: Macroscopic and microscopic tumor behavior during and after radiotherapy with curative intent. Schweiz Rundsch Med Prax 88 (1999) 1825-1836
22. Machtay M., Swann S., Komaki R., et al. Higher BED is associated with improved local-regional control and survival for NSCLC treated with chemoradiotherapy: An RTOG Analysis. Int J Radiat Oncol Biol Phys 63 Suppl 1 (2005) S40 (abstract 66)
23. Belani P.C., Choy H., Bonomi P., et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non small-cell lung cancer: A randomized Phase II locally advanced multi-modality protocol. J Clin Oncol 23 (2005) 5883-5891
24. Fournel P., Robinet G., Thomas P., et al. Randomized Phase III trial of sequential chemoradiotherapy compared with concurrent chemo-radiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 study. J Clin Oncol 23 (2005) 5910-5917
25. Zatloukal P., Peruzelka L., Zemanova M., et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized Phase II study. Lung Cancer 46 (2004) 87-98
26. Huber R.M., Flentje M., Schmidt M., et al. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable Stage IIIA or IIIB non small-cell lung cancer: Study CTRT 99/97 by the Bronchial Carcinoma Therapy Group. J Clin Oncol 24 (2006) 4397-4404
27. Vokes E.E. Optimal therapy for unresectable Stage III non-small-cell lung cancer. J Clin Oncol 23 (2005) 5853-5855
28. Extermann M., Overcash J., Lyman G.H., et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 16 (1998) 1582-1587
29. Firat S., Byhardt R.W., and Gore E. Comorbidity and Karnofsky performance score are independent prognostic factors in Stage III non-small-cell lung cancer: An institutional analysis of patients treated under RTOG studies. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 54 (2002) 357-364